OTCMDRKTF
Market cap1.92bUSD
Oct 15, Last price
3.00USD
Name
Darktrace PLC
Chart & Performance
P/E
32.57
P/S
3.34
EPS
0.09
Div Yield, %
0.00%
Shrs. gr., 5y
-0.57%
Rev. gr., 5y
47.02%
Revenues
576m
+51.29%
Net income
59m
+3,946.53%
CFO
150m
+16.31%
Profile
Darktrace plc, together with its subsidiaries, engages in the development and sale of cyber-threat defense technology solutions in the United Kingdom, the United States, Canada, Europe, and internationally. Its products include Enterprise Immune System to discover unpredictable cyber-threats; Industrial Immune System to detect novel threats and vulnerabilities, as well as safeguard the integrity and resilience of industrial technologies; and Cyber AI Analyst, an AI investigation technology, which automatically triages, interprets, and reports scope of security incidents. The company also provides Darktrace Antigena, an autonomous response technology for the enterprise with various security products that delivers proactive cyber defense to digital infrastructure. It serves critical national infrastructure organizations, financial services companies, technology and healthcare providers, media corporations, and educational institutions. The company was founded in 2013 and is headquartered in Cambridge, the United Kingdom.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | |
| Income | ||||||
Revenues | 575,592 51.29% | 380,468 29.96% | ||||
Cost of revenue | 531,791 | 406,343 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 43,802 | (25,875) | ||||
NOPBT Margin | 7.61% | |||||
Operating Taxes | (21,728) | 2,001 | ||||
Tax Rate | ||||||
NOPAT | 65,529 | (27,876) | ||||
Net income | 58,958 3,946.53% | 1,457 -100.97% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | (137,041) | (6,038) | ||||
BB yield | ||||||
| Debt | ||||||
Debt current | 4,873 | 3,718 | ||||
Long-term debt | 105,385 | 120,391 | ||||
Deferred revenue | 28,393 | 29,496 | ||||
Other long-term liabilities | 1,741 | 1,341 | ||||
Net debt | (246,152) | (267,366) | ||||
| Cash flow | ||||||
Cash from operating activities | 149,919 | 128,899 | ||||
CAPEX | (27,563) | (30,361) | ||||
Cash from investing activities | (27,563) | (63,078) | ||||
Cash from financing activities | (160,045) | (14,206) | ||||
FCF | 131,630 | (64,980) | ||||
| Balance | ||||||
Cash | 356,410 | 391,475 | ||||
Long term investments | ||||||
Excess cash | 327,631 | 372,452 | ||||
Stockholders' equity | 351,583 | 310,931 | ||||
Invested Capital | (260,678) | 83,630 | ||||
ROIC | ||||||
ROCE | 65.50% | |||||
| EV | ||||||
Common stock shares outstanding | 677,911 | 695,581 | ||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | 86,971 | 5,596 | ||||
EV/EBITDA | ||||||
Interest | 3,686 | 2,570 | ||||
Interest/NOPBT | 8.42% | |||||